title: Intravenous immunoglobulin in the Guillain-Barré syndrome. May cause severe adverse skin reactions.
authors.forename: H H
authors.initials: HH
authors.lastname: Hamdalla
authors.forename: C H
authors.initials: CH
authors.lastname: Hawkes
authors.forename: E G
authors.initials: EG
authors.lastname: Spokes
authors.forename: J M
authors.initials: JM
authors.lastname: Bamford
authors.forename: P J
authors.initials: PJ
authors.lastname: Goulding
mesh_terms: D000368:Aged; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011129:Polyradiculoneuropathy / Q000628:therapy*; D012871:Skin Diseases / Q000209:etiology*
chemical_list: D016756:Immunoglobulins, Intravenous